Jessica L. Markham
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jessica L. Markham has a total of 173 co-authors. Here are the top co-authors by number of shared publications:
Matt Hall
Children’s Hospital Association
15 shared publications- Matt Hall
Children's Hospital Association Lenexa Kansas USA
13 shared publications Jessica L. Bettenhausen
Department of Pediatrics Children's Mercy Kansas City Kansas City Missouri USA
12 shared publicationsJames C. Gay
Department of Pediatrics, Vanderbilt University School of Medicine, Monroe Carrell, Jr. Children’s Hospital at Vanderbilt, Nashville, Tennessee
8 shared publicationsMatthew Hall
Department of Pediatrics Children's Mercy Kansas City Kansas City Missouri USA
8 shared publications- Matthew J. Molloy
Cincinnati Children's Hospital Medical Center Cincinnati Ohio USA
7 shared publications
Latest Publications
- Open Access
- 7 October 2026
- Published by Wiley in Journal of Hospital Medicine
Medicaid utilization in children: Condition‐specific incidence and spending
Medicaid insures over half of US children, yet gaps remain in understanding how funds are allocated across the care of nonchronic conditions, the care of chronic conditions, and preventative services. We conducted a retrospective analysis of 7.2 million Medicaid‐enrolled children from 12 states in the 2022 Medicaid Marketscan database. Only 78.5% of enrolled children had a Medicaid healthcare claim. Among those with at least one Medicaid claim, half received preventative care, accounting for just 8.5% of total Medicaid spending. Care of nonchronic conditions accounted for the highest proportion (50.4%) of spending, while the care of chronic conditions affected 27.7% of children and represented 41.1% of spending. These findings highlight opportunities for preventive care and the need for strategies to increase access and optimize Medicaid's impact on children's health.
- 7 October 2026
- Published by Wiley in Journal of Hospital Medicine
Open AccessMedicaid utilization in children: Condition‐specific incidence and spending
Medicaid insures over half of US children, yet gaps remain in understanding how funds are allocated across the care of nonchronic conditions, the care of chronic conditions, and preventative services. We conducted a retrospective analysis of 7.2 million Medicaid‐enrolled children from 12 states in the 2022 Medicaid Marketscan database. Only 78.5% of enrolled children had a Medicaid healthcare claim. Among those with at least one Medicaid claim, half received preventative care, accounting for just 8.5% of total Medicaid spending. Care of nonchronic conditions accounted for the highest proportion (50.4%) of spending, while the care of chronic conditions affected 27.7% of children and represented 41.1% of spending. These findings highlight opportunities for preventive care and the need for strategies to increase access and optimize Medicaid's impact on children's health.
- Open Access
- 22 September 2026
- Published by Wiley in Journal of Hospital Medicine
Racial and ethnic differences in hospital‐based low‐value pediatric care
Background: Low‐value care (LVC), or care in which potential risk outweighs perceived benefits, continues to impact pediatric populations. While pediatric healthcare delivery is known to vary across racial and ethnic groups, little is known about the relationship between race and ethnicity and LVC. We sought to evaluate this relationship among hospitalized children. Methods: This cross‐sectional study applied the Pediatric Health Information System LVC Calculator to encounters from July 1, 2022 to June 30, 2024. We used generalized estimating equation models to analyze differences in LVC across seven groups (Non‐Hispanic White, Non‐Hispanic Black, Hispanic, Asian, American Indian or Alaska Native, Native Hawaiian or Pacific Islander, and Other or Multiracial). For measures with across‐group differences, we performed pairwise comparisons to assess differential odds of LVC receipt with the Non‐Hispanic White group as a referent. We then performed a subanalysis applying these methods to only the largest groups. Results: Of 14 eligible measures, LVC varied across racial and ethnic groups for seven. Patterns varied by measure, with no group demonstrating consistently high or low LVC. Measures with the greatest variation across groups included head computed tomography for first seizure, concurrent use of antipsychotics, and broad‐spectrum antibiotics for uncomplicated community‐acquired pneumonia. Our subanalysis demonstrated similar findings, with across‐group differences noted for eight measures. Conclusions: We identified differences in LVC receipt by race and ethnicity for some services among hospitalized patients, without consistency in patterns across measures. Further evaluation of drivers and outcomes associated with these patterns is needed; our findings may assist in prioritizing deimplementation efforts.
- 22 September 2026
- Published by Wiley in Journal of Hospital Medicine
Open AccessRacial and ethnic differences in hospital‐based low‐value pediatric care
Background: Low‐value care (LVC), or care in which potential risk outweighs perceived benefits, continues to impact pediatric populations. While pediatric healthcare delivery is known to vary across racial and ethnic groups, little is known about the relationship between race and ethnicity and LVC. We sought to evaluate this relationship among hospitalized children. Methods: This cross‐sectional study applied the Pediatric Health Information System LVC Calculator to encounters from July 1, 2022 to June 30, 2024. We used generalized estimating equation models to analyze differences in LVC across seven groups (Non‐Hispanic White, Non‐Hispanic Black, Hispanic, Asian, American Indian or Alaska Native, Native Hawaiian or Pacific Islander, and Other or Multiracial). For measures with across‐group differences, we performed pairwise comparisons to assess differential odds of LVC receipt with the Non‐Hispanic White group as a referent. We then performed a subanalysis applying these methods to only the largest groups. Results: Of 14 eligible measures, LVC varied across racial and ethnic groups for seven. Patterns varied by measure, with no group demonstrating consistently high or low LVC. Measures with the greatest variation across groups included head computed tomography for first seizure, concurrent use of antipsychotics, and broad‐spectrum antibiotics for uncomplicated community‐acquired pneumonia. Our subanalysis demonstrated similar findings, with across‐group differences noted for eight measures. Conclusions: We identified differences in LVC receipt by race and ethnicity for some services among hospitalized patients, without consistency in patterns across measures. Further evaluation of drivers and outcomes associated with these patterns is needed; our findings may assist in prioritizing deimplementation efforts.
- Open Access
- 10 September 2026
- Published by Wiley in Journal of Hospital Medicine
Variation in blood culture testing in children hospitalized with three common infections
Background: Routine blood culture (BCx) testing in uncomplicated community‐acquired pneumonia (CAP), skin and soft tissue infections (SSTI), and urinary tract infections (UTI) has demonstrated low clinical utility. Objectives: To evaluate hospital‐level BCx testing trends and their association with clinical outcomes for children hospitalized with CAP, SSTI, and UTI. Methods: This retrospective cohort study used the Pediatric Health Information System database to identify hospitalizations of children aged 3 months–18 years with CAP, SSTI, and UTI from 2016 to 2024. We excluded patients with complicated infections, complex chronic conditions, intensive care unit admission, or length of stay (LOS) > 7 days. Hospital‐level BCx testing rates were calculated by infection type, and annual trends were examined. Hospitals were grouped into low, moderate, and high BCx testing groups. Outcomes including LOS, costs, readmissions, and emergency department revisits were compared across hospital groups, adjusting for infection type, age, and illness severity. Results: Among 133,783 encounters across 37 hospitals, BCxs were obtained in 42% hospitalizations for CAP, 46% for SSTI, and 56% for UTI hospitalizations with substantial hospital‐level variation (e.g., 14%–77% for CAP). Over time, four hospitals showed significant increases, eight showed decreases, and 25 showed no change in annual BCx testing. No clinically significant differences in outcomes were observed across low ( n = 15), moderate ( n = 14), or high ( n = 8) hospital testing groups. Conclusions: BCx testing remains frequent for CAP, SSTI, and UTI with a minority of hospitals demonstrating testing reductions over time. The frequency of BCx testing and lack of significant differences in outcomes suggests opportunities for diagnostic stewardship.
- 10 September 2026
- Published by Wiley in Journal of Hospital Medicine
Open AccessVariation in blood culture testing in children hospitalized with three common infections
Background: Routine blood culture (BCx) testing in uncomplicated community‐acquired pneumonia (CAP), skin and soft tissue infections (SSTI), and urinary tract infections (UTI) has demonstrated low clinical utility. Objectives: To evaluate hospital‐level BCx testing trends and their association with clinical outcomes for children hospitalized with CAP, SSTI, and UTI. Methods: This retrospective cohort study used the Pediatric Health Information System database to identify hospitalizations of children aged 3 months–18 years with CAP, SSTI, and UTI from 2016 to 2024. We excluded patients with complicated infections, complex chronic conditions, intensive care unit admission, or length of stay (LOS) > 7 days. Hospital‐level BCx testing rates were calculated by infection type, and annual trends were examined. Hospitals were grouped into low, moderate, and high BCx testing groups. Outcomes including LOS, costs, readmissions, and emergency department revisits were compared across hospital groups, adjusting for infection type, age, and illness severity. Results: Among 133,783 encounters across 37 hospitals, BCxs were obtained in 42% hospitalizations for CAP, 46% for SSTI, and 56% for UTI hospitalizations with substantial hospital‐level variation (e.g., 14%–77% for CAP). Over time, four hospitals showed significant increases, eight showed decreases, and 25 showed no change in annual BCx testing. No clinically significant differences in outcomes were observed across low ( n = 15), moderate ( n = 14), or high ( n = 8) hospital testing groups. Conclusions: BCx testing remains frequent for CAP, SSTI, and UTI with a minority of hospitals demonstrating testing reductions over time. The frequency of BCx testing and lack of significant differences in outcomes suggests opportunities for diagnostic stewardship.
- Open Access
- 8 September 2026
- Published by Cambridge University Press (CUP) in Antimicrobial Stewardship & Healthcare Epidemiology
- Vol. 6 (1) , e257
Trends and demographic predictors of cefdinir use for common bacterial infections in children enrolled in Medicaid, 2016–2023
Objectives: To determine trends and predictors of cefdinir use for common pediatric infections in the United States. Design: Retrospective cohort study, 2016–2023. Setting: U.S. outpatient encounters (ambulatory, emergency department, urgent care) included in the Medicaid MarketScan database. Patients: Children aged 0–18 years diagnosed with bacterial rhinosinusitis, pharyngitis, urinary tract infection (UTI), acute otitis media (AOM), or community-acquired pneumonia (CAP). Methods: We assessed cefdinir prescription rates by diagnosis and year, comparing to other commonly administered antibiotics. We used logistic regression to identify demographic predictors of cefdinir use. Results: Among 7,346,547 encounters, most common diagnoses were AOM (36.9%) and bacterial pharyngitis (36.2%). Patients were predominantly non-Hispanic White (53.0%), 1–5 years-old (41.1%), and seen in ambulatory settings (75.3%). Cefdinir was prescribed in 10.4% of encounters, ranking among the top prescribed antibiotics. After an initial increase, use declined post-2020 to 7.6%. In children 1–18 years-old, younger age was uniformly associated with higher odds of cefdinir prescription across all diagnoses. This pattern was inconsistent among infants <1 years-old across diagnoses but persisted for UTI, with ORs of 9.38 (95% CI, 8.91–9.88) for <1 years-old and 5.91 (95% CI, 5.76–6.06) for 1–5 years-old versus 15–18 years-old patients. NH Black patients and those seen in urgent care or the emergency department were less likely to receive cefdinir. Conclusions: Despite a small decline in use since 2020, cefdinir use remains substantial, especially among young children with UTI. Continued efforts to reduce inappropriate use and promote antibiotic stewardship are warranted.
- 8 September 2026
- Published by Cambridge University Press (CUP) in Antimicrobial Stewardship & Healthcare Epidemiology
- Vol. 6 (1) , e257
Open AccessTrends and demographic predictors of cefdinir use for common bacterial infections in children enrolled in Medicaid, 2016–2023
Objectives: To determine trends and predictors of cefdinir use for common pediatric infections in the United States. Design: Retrospective cohort study, 2016–2023. Setting: U.S. outpatient encounters (ambulatory, emergency department, urgent care) included in the Medicaid MarketScan database. Patients: Children aged 0–18 years diagnosed with bacterial rhinosinusitis, pharyngitis, urinary tract infection (UTI), acute otitis media (AOM), or community-acquired pneumonia (CAP). Methods: We assessed cefdinir prescription rates by diagnosis and year, comparing to other commonly administered antibiotics. We used logistic regression to identify demographic predictors of cefdinir use. Results: Among 7,346,547 encounters, most common diagnoses were AOM (36.9%) and bacterial pharyngitis (36.2%). Patients were predominantly non-Hispanic White (53.0%), 1–5 years-old (41.1%), and seen in ambulatory settings (75.3%). Cefdinir was prescribed in 10.4% of encounters, ranking among the top prescribed antibiotics. After an initial increase, use declined post-2020 to 7.6%. In children 1–18 years-old, younger age was uniformly associated with higher odds of cefdinir prescription across all diagnoses. This pattern was inconsistent among infants <1 years-old across diagnoses but persisted for UTI, with ORs of 9.38 (95% CI, 8.91–9.88) for <1 years-old and 5.91 (95% CI, 5.76–6.06) for 1–5 years-old versus 15–18 years-old patients. NH Black patients and those seen in urgent care or the emergency department were less likely to receive cefdinir. Conclusions: Despite a small decline in use since 2020, cefdinir use remains substantial, especially among young children with UTI. Continued efforts to reduce inappropriate use and promote antibiotic stewardship are warranted.
- Open Access
- 5 March 2026
- Published by Wiley in Journal of Hospital Medicine
Trends in hospitalizations for vaccine‐preventable diseases in the United States from 2014 to 2024
Background and Objectives: Vaccination rates have declined in recent years, resulting in outbreaks of vaccine‐preventable diseases (VPDs) among children. We aimed to evaluate VPD hospitalization rates from 2014 to 2024 and to report associated trends in outcomes including intensive care utilization, mortality, readmissions, and costs. Methods: Trends in hospitalizations due to VPDs were examined from July 1, 2014, to June 30, 2024, among patients aged 0–18 at US children's hospitals within the Pediatric Health Information System database using seasonal autoregressive integrated moving average models. Subanalyses were conducted to examine trends in hospitalization rates and outcomes for children with medical complexity and immune‐compromising conditions. Results: We identified 160,435 hospitalizations for VPDs, most commonly due to influenza (112,074 [70%]), pneumococcus (16,592 [10%]), Haemophilus influenzae (14,086 [9%]), and rotavirus (10,917 [7%]). Rates of hospitalizations due to all VPDs for the total cohort exhibited seasonal variation and increased over time, with a break in expected trends during the COVID‐19 pandemic. Mean total adjusted cost for VPD hospitalizations per year was $610 million and increased over time. Nearly 25% ( n = 39,223) of children required intensive care and 0.8% ( n = 1345) died. Children with medical complexity and immune‐compromising conditions experienced higher rates of hospitalization due to VPDs as well as higher cost, readmission rates, and mortality. Conclusions: Pediatric VPD hospitalization rates have increased over time. Children with medical complexity and immune‐compromising conditions are disproportionately impacted by VPD hospitalizations. Addressing vaccination hesitancy and barriers to vaccination has the potential to impact healthcare costs and outcomes for children.
- 5 March 2026
- Published by Wiley in Journal of Hospital Medicine
Open AccessTrends in hospitalizations for vaccine‐preventable diseases in the United States from 2014 to 2024
Background and Objectives: Vaccination rates have declined in recent years, resulting in outbreaks of vaccine‐preventable diseases (VPDs) among children. We aimed to evaluate VPD hospitalization rates from 2014 to 2024 and to report associated trends in outcomes including intensive care utilization, mortality, readmissions, and costs. Methods: Trends in hospitalizations due to VPDs were examined from July 1, 2014, to June 30, 2024, among patients aged 0–18 at US children's hospitals within the Pediatric Health Information System database using seasonal autoregressive integrated moving average models. Subanalyses were conducted to examine trends in hospitalization rates and outcomes for children with medical complexity and immune‐compromising conditions. Results: We identified 160,435 hospitalizations for VPDs, most commonly due to influenza (112,074 [70%]), pneumococcus (16,592 [10%]), Haemophilus influenzae (14,086 [9%]), and rotavirus (10,917 [7%]). Rates of hospitalizations due to all VPDs for the total cohort exhibited seasonal variation and increased over time, with a break in expected trends during the COVID‐19 pandemic. Mean total adjusted cost for VPD hospitalizations per year was $610 million and increased over time. Nearly 25% ( n = 39,223) of children required intensive care and 0.8% ( n = 1345) died. Children with medical complexity and immune‐compromising conditions experienced higher rates of hospitalization due to VPDs as well as higher cost, readmission rates, and mortality. Conclusions: Pediatric VPD hospitalization rates have increased over time. Children with medical complexity and immune‐compromising conditions are disproportionately impacted by VPD hospitalizations. Addressing vaccination hesitancy and barriers to vaccination has the potential to impact healthcare costs and outcomes for children.
- 21 October 2025
- Published by Wiley in Journal of Hospital Medicine
- Vol. 21 (1) , 49-58
Antibiotic susceptibility patterns in US children's hospitals
Background: Antibiograms are important tools to guide empirical antibiotic selection. Aggregate antibiograms for children can provide guidance when local data are scarce (e.g., unavailable, insufficient isolates) and support regional and national comparisons; however, aggregate reporting is limited. Objective(s): To examine antibiotic susceptibility patterns for children and to compare patterns of resistance by isolate source and geographic region. Methods: A request for submission of the most recent institutional antibiogram was sent to 51 US children′s hospitals in April 2023. Data elements were transcribed and standardized to facilitate aggregate analysis. Aggregate antibiograms were generated, and logistic regression was performed to examine regional differences in susceptibilities. Results: We received 46 institutional antibiograms. Antibiograms varied in presentation including the number and types of bacteria and antibiotics, reporting by specimen source (e.g., urine) and location (i.e., hospital unit). Staphylococcus spp. were the most frequently reported Gram‐positive bacteria. Of the more than 35,000 Staphylococcus aureus isolates, 35.4% were identified as methicillin resistant and nearly 80% were susceptible to clindamycin. Escherichia coli and Klebsiella spp . were the most frequently reported Gram‐negative bacteria with 85.4% and 84.1% of isolates, respectively, demonstrating susceptibility to cefazolin. Regional differences in susceptibilities were observed. For example, S. aureus isolates from hospitals located in the Southern region of the United States had the lowest susceptibility to oxacillin. Conclusions: This study provides regional and national data on pediatric antibiotic susceptibilities at US children′s hospitals. Many opportunities exist for the use and reporting of aggregate antibiograms to enhance antimicrobial stewardship processes and monitor changes in antimicrobial resistance.
- 21 October 2025
- Published by Wiley in Journal of Hospital Medicine
- Vol. 21 (1) , 49-58
Antibiotic susceptibility patterns in US children's hospitals
Background: Antibiograms are important tools to guide empirical antibiotic selection. Aggregate antibiograms for children can provide guidance when local data are scarce (e.g., unavailable, insufficient isolates) and support regional and national comparisons; however, aggregate reporting is limited. Objective(s): To examine antibiotic susceptibility patterns for children and to compare patterns of resistance by isolate source and geographic region. Methods: A request for submission of the most recent institutional antibiogram was sent to 51 US children′s hospitals in April 2023. Data elements were transcribed and standardized to facilitate aggregate analysis. Aggregate antibiograms were generated, and logistic regression was performed to examine regional differences in susceptibilities. Results: We received 46 institutional antibiograms. Antibiograms varied in presentation including the number and types of bacteria and antibiotics, reporting by specimen source (e.g., urine) and location (i.e., hospital unit). Staphylococcus spp. were the most frequently reported Gram‐positive bacteria. Of the more than 35,000 Staphylococcus aureus isolates, 35.4% were identified as methicillin resistant and nearly 80% were susceptible to clindamycin. Escherichia coli and Klebsiella spp . were the most frequently reported Gram‐negative bacteria with 85.4% and 84.1% of isolates, respectively, demonstrating susceptibility to cefazolin. Regional differences in susceptibilities were observed. For example, S. aureus isolates from hospitals located in the Southern region of the United States had the lowest susceptibility to oxacillin. Conclusions: This study provides regional and national data on pediatric antibiotic susceptibilities at US children′s hospitals. Many opportunities exist for the use and reporting of aggregate antibiograms to enhance antimicrobial stewardship processes and monitor changes in antimicrobial resistance.
- 9 October 2025
- Published by Wiley in Journal of Hospital Medicine
- Vol. 21 (4) , 380-390
Frequency, cost, and variation in inpatient diagnostic imaging use in children′s hospitals
Background: Diagnostic imaging studies are frequently utilized when caring for pediatric patients. The most prevalent and costly imaging studies among hospitalized children are unknown. Objective: Identify imaging studies with highest frequency, cost, rates of repetition, and hospital variation among hospitalized children, including patients with intensive care (ICU) stays and complex chronic conditions (CCCs). Methods: We performed a retrospective cohort study of patients hospitalized from January 1, 2021 to December 31, 2022 across 45 children′s hospitals in the Pediatric Health Information System. We identified diagnostic imaging studies for inpatient and observation encounters using billing codes grouped by body system and modality. We measured imaging frequency, costs, and variation across hospitals, overall and for ICU stays and children with CCCs. Results: We identified 1,523,343 encounters; 59.1% had imaging, with $2.03 billion in imaging costs. The most frequently obtained and repeated imaging included chest X‐ray (CXR), abdominal X‐ray, and cardiovascular (CV) ultrasound/echocardiography. The imaging studies with highest cumulative cost were cardiovascular ultrasound, CXR, and neuro/head MRI. ICU encounters were 15.1% of total encounters, but accounted for 44.6% of imaging costs; CCC encounters were 39.6% of the total but accounted for 74.2% of costs. Interhospital variation was low among the most frequent and costly imaging modalities. Conclusions: Among a cohort of hospitalized children, CXR and CV ultrasounds were among the most prevalent, costly, and frequently repeated imaging studies. Encounters with ICU stays and for patients with CCCs incurred disproportionate imaging costs. Our results serve as a starting point for identifying imaging overuse and developing achievable benchmarks of care.
- 9 October 2025
- Published by Wiley in Journal of Hospital Medicine
- Vol. 21 (4) , 380-390
Frequency, cost, and variation in inpatient diagnostic imaging use in children′s hospitals
Background: Diagnostic imaging studies are frequently utilized when caring for pediatric patients. The most prevalent and costly imaging studies among hospitalized children are unknown. Objective: Identify imaging studies with highest frequency, cost, rates of repetition, and hospital variation among hospitalized children, including patients with intensive care (ICU) stays and complex chronic conditions (CCCs). Methods: We performed a retrospective cohort study of patients hospitalized from January 1, 2021 to December 31, 2022 across 45 children′s hospitals in the Pediatric Health Information System. We identified diagnostic imaging studies for inpatient and observation encounters using billing codes grouped by body system and modality. We measured imaging frequency, costs, and variation across hospitals, overall and for ICU stays and children with CCCs. Results: We identified 1,523,343 encounters; 59.1% had imaging, with $2.03 billion in imaging costs. The most frequently obtained and repeated imaging included chest X‐ray (CXR), abdominal X‐ray, and cardiovascular (CV) ultrasound/echocardiography. The imaging studies with highest cumulative cost were cardiovascular ultrasound, CXR, and neuro/head MRI. ICU encounters were 15.1% of total encounters, but accounted for 44.6% of imaging costs; CCC encounters were 39.6% of the total but accounted for 74.2% of costs. Interhospital variation was low among the most frequent and costly imaging modalities. Conclusions: Among a cohort of hospitalized children, CXR and CV ultrasounds were among the most prevalent, costly, and frequently repeated imaging studies. Encounters with ICU stays and for patients with CCCs incurred disproportionate imaging costs. Our results serve as a starting point for identifying imaging overuse and developing achievable benchmarks of care.
- 2 October 2025
- Published by Wiley in Journal of Hospital Medicine
- Vol. 21 (4) , 447-448
Securing benefits of crisis‐driven innovations
- 2 October 2025
- Published by Wiley in Journal of Hospital Medicine
- Vol. 21 (4) , 447-448
Securing benefits of crisis‐driven innovations
- 2 October 2025
- Published by Wiley in Journal of Hospital Medicine
- Vol. 21 (1) , 89-92
The institutional antibiogram: Time for a makeover?
- 2 October 2025
- Published by Wiley in Journal of Hospital Medicine
- Vol. 21 (1) , 89-92
The institutional antibiogram: Time for a makeover?
- 13 January 2025
- Published by Wiley in Journal of Hospital Medicine
- Vol. 20 (8) , 853-857
Accuracy of pathogen diagnostic codes for acute hematogenous musculoskeletal infections in children
Administrative databases are powerful tools for pediatric research but lack patient‐level microbiology results. This study aimed to determine the accuracy of pathogen discharge diagnosis codes for children hospitalized with acute hematogenous musculoskeletal infections (MSKIs). Medical records for 244 children hospitalized with acute hematogenous MSKIs were manually reviewed to determine which bacterial pathogen, if any, was identified for each MSKI based on microbiology results obtained during the hospitalization. Microbiology results for each patient were then compared to their discharge diagnoses in the Pediatric Health Information System (PHIS) database to determine the accuracy of pathogen discharge codes. Discharge diagnostic codes correctly matched the microbiology results in 89.3% of encounters. Sensitivity and specificity for Staphylococcus aureus discharge diagnostic codes were 88.6% and 96.4% respectively for methicillin‐susceptible S. aureus and 92.9% and 99.5% for methicillin‐resistant S. aureus . Pathogen discharge codes are reliable surrogates that accurately reflect the microbiology results for children with MSKIs.
- 13 January 2025
- Published by Wiley in Journal of Hospital Medicine
- Vol. 20 (8) , 853-857
Accuracy of pathogen diagnostic codes for acute hematogenous musculoskeletal infections in children
Administrative databases are powerful tools for pediatric research but lack patient‐level microbiology results. This study aimed to determine the accuracy of pathogen discharge diagnosis codes for children hospitalized with acute hematogenous musculoskeletal infections (MSKIs). Medical records for 244 children hospitalized with acute hematogenous MSKIs were manually reviewed to determine which bacterial pathogen, if any, was identified for each MSKI based on microbiology results obtained during the hospitalization. Microbiology results for each patient were then compared to their discharge diagnoses in the Pediatric Health Information System (PHIS) database to determine the accuracy of pathogen discharge codes. Discharge diagnostic codes correctly matched the microbiology results in 89.3% of encounters. Sensitivity and specificity for Staphylococcus aureus discharge diagnostic codes were 88.6% and 96.4% respectively for methicillin‐susceptible S. aureus and 92.9% and 99.5% for methicillin‐resistant S. aureus . Pathogen discharge codes are reliable surrogates that accurately reflect the microbiology results for children with MSKIs.